Onepot AI Secures $13M Seed Funding Led by Fifty Years

Why It Matters

Accelerating and automating chemical synthesis removes a major bottleneck in drug development, lowering costs and enabling faster testing of novel compounds, which could reshape R&D pipelines for pharma and biotech and reduce reliance on overseas contract labs.

Deal Summary

AI-driven chemistry startup Onepot AI announced a $13 million seed round, led by Fifty Years, with participation from Khosla Ventures, Speedinvest, OpenAI co‑founder Wojciech Zaremba and Google scientist Jeff Dean. The funding will support building a second lab in San Francisco and expanding its small‑molecule synthesis platform for biotech and pharma customers.